Cargando…

Screening therapeutic targets of ribavirin in hepatocellular carcinoma

The objective of the present study was to screen the key genes of ribavirin in hepatocellular carcinoma (HCC) and provide novel therapeutic targets for HCC treatment. The mRNA expression datasets of GSE23031 and GSE74656, as well as the microRNA (miRNA) expression dataset of GSE22058 were downloaded...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chen, Luo, Liyun, Yu, Yongjun, Zhang, Zhao, Zhang, Yi, Li, Haimei, Cheng, Yue, Qin, Hai, Zhang, Xipeng, Ma, Hongmei, Li, Yuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958667/ https://www.ncbi.nlm.nih.gov/pubmed/29805683 http://dx.doi.org/10.3892/ol.2018.8552

Ejemplares similares

Transvaginal Mesh and Transanal Resection to Treat Outlet Obstruction Constipation Caused by Rectocele
por: Shi, Yang, et al.
Publicado: (2017)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment
por: Wang, Jukun, et al.
Publicado: (2021)

Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Wu, Linghong, et al.
Publicado: (2022)

The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
por: Sun, Jie, et al.
Publicado: (2019)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
por: Qi, Shibo, et al.
Publicado: (2014)

CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasis
por: Zhang, Bei, et al.
Publicado: (2023)

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
por: Zhou, Dong-Sheng, et al.
Publicado: (2015)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

Adenomatous Polyposis Coli Gene Mutations in 22 Chinese Pedigrees with Familial Adenomatous Polyposis
por: Wang, Dan, et al.
Publicado: (2019)

Analysis of expression levels of markers associated with tumor proliferation and angiogenesis in familial adenomatous polyposis
por: Zhang, Zhao, et al.
Publicado: (2020)

Targeted next‐generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis
por: Wang, Dan, et al.
Publicado: (2018)

Nosip is a potential therapeutic target in hepatocellular carcinoma cells
por: Gao, Junjie, et al.
Publicado: (2023)

Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects
por: Xiao, Zhangang, et al.
Publicado: (2018)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis
por: Ye, Jiaxiang, et al.
Publicado: (2020)

Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
por: Zhao, Qianwei, et al.
Publicado: (2020)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma
por: Jia, Qingan, et al.
Publicado: (2017)

Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma
por: Li, Tiejun, et al.
Publicado: (2016)

Quantitative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Laryngeal Carcinoma
por: Li, Li, et al.
Publicado: (2014)

Repurposing Dimetridazole and Ribavirin to disarm Pseudomonas aeruginosa virulence by targeting the quorum sensing system
por: Yuan, Yang, et al.
Publicado: (2022)

MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689
por: Zeng, Hui, et al.
Publicado: (2019)

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
por: Qian, Yunsong, et al.
Publicado: (2022)

Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors
por: Casaos, Joshua, et al.
Publicado: (2018)

Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma
por: Zhang, Junyong, et al.
Publicado: (2016)

Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
por: Li, Lin, et al.
Publicado: (2017)

Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma
por: Liang, Xiao-Dong, et al.
Publicado: (2014)

Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
por: Bouattour, Mohamed, et al.
Publicado: (2018)

Sgo1 is a potential therapeutic target for hepatocellular carcinoma
por: Wang, Lyu-Han, et al.
Publicado: (2015)

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018)

A Panel of E2F Target Gene Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Hu, Wenmin, et al.
Publicado: (2022)

Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Chen, Xia, et al.
Publicado: (2020)

DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism
por: Li, Guangtao, et al.
Publicado: (2022)

Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma
por: Wang, Jiang, et al.
Publicado: (2023)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
por: Hu, Ching-Chih, et al.
Publicado: (2018)

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
por: Li, Xiaoju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8r0t57hr3b4imdaodcidee519k